TheFly.com
XENE
Xenon Pharmaceuticals
$
()
Xenon Pharmaceuticals price target raised by $13 at Guggenheim, here's why
Xenon Pharmaceuticals price target raised by $12 at Needham, here's why
Xenon Pharmaceuticals price target raised by $5 at Wedbush, here's why
Xenon Pharmaceuticals price target raised by $7 at Wells Fargo, here's why
Xenon Pharmaceuticals reports Q4 EPS (64c), consensus (76c)
Xenon Pharmaceuticals outlines milestone opportunities for 2024
Xenon Pharmaceuticals initiated with bullish view at Citi, here's why
Xenon Pharmaceuticals price target raised by $4 at BofA, here's why
Xenon Pharmaceuticals initiated with bullish view at Baird, here's why
Xenon Pharmaceuticals initiated with bullish view at Baird
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
Copyright ©1998-2024 Thefly.com LLC
